Sphere Medical Holding (LSE:SPHR) EBIT : £-5.14 Mil (TTM As of Dec. 2016)

View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding EBIT?

Sphere Medical Holding's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2016 was £-2.50 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2016 was £-5.14 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sphere Medical Holding's annualized ROC % for the quarter that ended in Dec. 2016 was -185.93%. Sphere Medical Holding's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2016 was -2,479.40%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sphere Medical Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2016 was 192.26%.

Sphere Medical Holding EBIT Historical Data

The historical data trend for Sphere Medical Holding's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding EBIT Chart

Sphere Medical Holding Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

EBIT

Get a 7-Day Free Trial

-7.76

-5.52

-5.87

-6.11

-5.14

Sphere Medical Holding Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
EBIT	Get a 7-Day Free Trial						-2.87	-3.49	-2.63	-2.64	-2.50

Competitive Comparison of Sphere Medical Holding's EBIT

For the Medical Devices subindustry, Sphere Medical Holding's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sphere Medical Holding's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's EV-to-EBIT falls into.

Sphere Medical Holding EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-5.14 Mil.

Sphere Medical Holding (LSE:SPHR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sphere Medical Holding's annualized ROC % for the quarter that ended in Dec. 2016 is calculated as:

	ROC % (Q: Dec. 2016 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2016 )	+	Invested Capital (Q: Dec. 2016 ))	/ count )
=	-4.996 * ( 1 - 0% )	/	( (2.244	+	3.13)	/ 2 )
=	-4.996	/	2.687
=	-185.93 %

where

	Invested Capital		(Q: Jun. 2016 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	9.464	-	0.823	-	( 6.637	-	max(0, 0.823	-	7.22	+	6.637	))
=	2.244

	Invested Capital		(Q: Dec. 2016 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	6.966	-	0.744	-	( 3.241	-	max(0, 0.757	-	3.849	+	3.241	))
=	3.13

Note: The Operating Income data used here is two times the semi-annual (Dec. 2016) data.

2. Joel Greenblatt's definition of Return on Capital:

Sphere Medical Holding's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2016 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2016 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2016		Q: Dec. 2016
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-4.996	/	( ( (0.214 + max(-0.39, 0))	+	(0.189 + max(-0.306, 0)) )	/	2 )
=	-4.996	/	( ( 0.214	+	0.189 )	/	2 )
=	-4.996	/	0.2015
=	-2,479.40 %

where Working Capital is:

	Working Capital		(Q: Jun. 2016 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0.433	+	0)	-	(0.823	+	0	+	0)
=	-0.39

	Working Capital		(Q: Dec. 2016 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.024	+	0.427	+	0)	-	(0.744	+	0	+	0.013)
=	-0.306

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2016) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sphere Medical Holding's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2016 )
	=	-5.141	/	-2.674
	=	192.26 %

Sphere Medical Holding EBIT Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sphere Medical Holding (LSE:SPHR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harston Mill, Harston, Cambridge, GBR, CB22 7GG

Website

http://www.spheremedical.com

Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.